Planning, implementation, and initial results of newborn screening for Pompe disease and MPS I in Georgia

被引：2
|
作者：
Foley, Allison [1 ]
Cagle, Stephanie [1 ]
Hagar, Arthur [2 ]
Hall, Patricia [3 ]
Laney, Dawn [1 ]
Russo, Rossana Sanchez [1 ]
Wittenauer, Angela [1 ]
Wilcox, William R. [1 ]
机构：
[1] Emory Univ, Decatur, GA USA
[2] Georgia Dept Publ Hlth, Decatur, GA USA
[3] EGL Genet Eurofins Clin Diagnost, Tucker, GA USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2018年 / 123卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2017.12.107
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
98
引用
收藏
页码：S47 / S47
页数：1
相关论文
共 50 条
  • [31] Newborn screening for Pompe disease: The Washington, DC experience
    Grant, Christina L.
    Shaw, Allison A.
    Kuperman, KerriAnn
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S50 - S51
  • [32] High prevalence of pseudodeficiency for MPS I and MPS II and the impact on newborn screening
    Pollard, Laura
    Wood, Tim
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S130 - S131
  • [33] Newborn screening for Pompe disease: Synthesis of the evidence and development of screening recommendations
    Kemper, Alex R.
    Hwu, Wuh-Liang
    Lloyd-Puryear, Michele
    Kishnani, Priya S.
    PEDIATRICS, 2007, 120 (05) : E1327 - E1334
  • [34] Oregon's experience with newborn screening for Fabry disease, Gaucher disease, Pompe disease and mucopolysaccharidosis type I
    Viall, Sarah
    Dennis, Anna
    Denniston, Sara
    Yang, Amy
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S108 - S108
  • [35] Newborn screening for MPS I - an update of the Washington, DC experience
    Lal, Tamanna R. Roshan
    Grant, Christina
    Crosby, Kathleen
    Hicks, Rebecca
    Viall, Sarah
    Rivers, Bryana
    Julca, Diana
    Tanpaiboon, Pranoot
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S140 - S140
  • [36] Newborn screening of Pompe disease in Japan: 2 years experience
    Momosaki, Ken
    Yoshida, Shinichiro
    Matsumoto, Shirou
    Nakamura, Kimitoshi
    Mitsubuchi, Hiroshi
    Endo, Fumio
    MOLECULAR GENETICS AND METABOLISM, 2015, 114 (02) : S82 - S82
  • [37] Advances in newborn screening for Pompe disease and resulting clinical outcomes
    Chien, Yin-Hsiu
    Hwu, Wuh-Liang
    Lee, Ni-Chung
    EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (01): : 21 - 29
  • [38] The First Year Experience of Newborn Screening for Pompe Disease in California
    Tang, Hao
    Feuchtbaum, Lisa
    Sciortino, Stanley
    Matteson, Jamie
    Mathur, Deepika
    Bishop, Tracey
    Olney, Richard S.
    INTERNATIONAL JOURNAL OF NEONATAL SCREENING, 2020, 6 (01)
  • [39] Expanding Newborn Screening for Pompe Disease in the United States: The NewSTEPs New Disorders Implementation Project, a Resource for New Disorder Implementation
    Hale, Kshea
    Kellar-Guenther, Yvonne
    McKasson, Sarah
    Singh, Sikha
    Ojodu, Jelili
    INTERNATIONAL JOURNAL OF NEONATAL SCREENING, 2020, 6 (02)
  • [40] NEWBORN SCREENING FOR MUCOPOLYSACCHARIDOSIS I (MPS I) BY DRIED BLOOD SPOTS IN TAIWAN
    Lin, S-P
    Lin, D-S
    Chang, J-H
    Lin, H-Y
    Wang, T-J
    Huang, S-F
    Chuang, C-K
    JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 : S89 - S89
12345